Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Limited cross-variant neutralization after primary Omicron infection: consideration for a variant-containing booster

Published:2022-08-22 Issue:1 Volume:7 Page:
ISSN:2059-3635
Container-title:Signal Transduction and Targeted Therapy
language:en
Short-container-title:Sig Transduct Target Ther

Author:

Marcotte Harold,Hammarström Lennart,Pan-Hammarström Qiang

Funder

EC | Horizon 2020 Framework Programme

Svenska Forskningsrådet Formas

Knut och Alice Wallenbergs Stiftelse

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Genetics

Link

https://www.nature.com/articles/s41392-022-01146-0.pdf

Reference5 articles.

1. Suryawanshi, R. K. et al. Limited cross-variant immunity from SARS-CoV-2 Omicron without vaccination. Nature https://doi.org/10.1038/s41586-022-04865-0 (2022)

2. Cao, Y. et al. BA.2.12.1, BA.4 and BA.5 escape antibodies elicited by Omicron infection. Nature https://doi.org/10.1038/s41586-022-04980-y (2022).

3. Tuekprakhon, A. et al. Antibody escape of SARS-CoV-2 Omicron BA.4 and BA.5 from vaccine and BA.1 serum. Cell https://doi.org/10.1016/j.cell.2022.06.005 (2022).

4. Muecksch, F. et al. Increased memory B cell potency and breadth after a SARS-CoV-2 mRNA boost. Nature https://doi.org/10.1038/s41586-022-04778-y (2022).

5. Zuo, F. et al. Heterologous immunization with inactivated vaccine followed by mRNA-booster elicits strong immunity against SARS-CoV-2 Omicron variant. Nat. Commun. 13, 2670 (2022).

Cited by 8 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Three in one: An effective and universal vaccine expressing heterologous tandem RBD trimer by rabies virus vector protects mice against SARS-CoV-2;Antiviral Research;2024-07

2. Conversion of monoclonal IgG to dimeric and secretory IgA restores neutralizing ability and prevents infection of Omicron lineages;Proceedings of the National Academy of Sciences;2024-01-09

3. Protection of the receptor binding domain (RBD) dimer against SARS-CoV-2 and its variants;Journal of Virology;2023-11-30

4. Neutralizing Activity of SARS-CoV-2 Antibodies in Patients with COVID-19 and Vaccinated Individuals;Antibodies;2023-09-25

5. Heterologous inactivated virus/mRNA vaccination response to BF.7, BQ.1.1, and XBB.1;The Lancet Regional Health - Western Pacific;2023-04

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3